Does LIFITEGRAST Cause Product dose omission issue? 276 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 276 reports of Product dose omission issue have been filed in association with LIFITEGRAST (Xiidra). This represents 2.1% of all adverse event reports for LIFITEGRAST.
276
Reports of Product dose omission issue with LIFITEGRAST
2.1%
of all LIFITEGRAST reports
1
Deaths
30
Hospitalizations
How Dangerous Is Product dose omission issue From LIFITEGRAST?
Of the 276 reports, 1 (0.4%) resulted in death, 30 (10.9%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LIFITEGRAST. However, 276 reports have been filed with the FAERS database.
What Other Side Effects Does LIFITEGRAST Cause?
Eye irritation (2,486)
Vision blurred (2,465)
Drug ineffective (1,373)
Instillation site pain (1,281)
Dysgeusia (1,067)
Eye pain (1,032)
Instillation site reaction (1,019)
Dry eye (1,013)
Ocular hyperaemia (570)
Lacrimation increased (547)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which LIFITEGRAST Alternatives Have Lower Product dose omission issue Risk?
LIFITEGRAST vs LIMAPROST
LIFITEGRAST vs LINACLOTIDE
LIFITEGRAST vs LINAGLIPTIN
LIFITEGRAST vs LINAGLIPTIN\METFORMIN
LIFITEGRAST vs LINCOMYCIN